GNC launches sports nutrition range for 'ultra serious' athletic men

By Stephen Daniells

- Last updated on GMT

The sports nutrition market in North America is worth $3.2bn
The sports nutrition market in North America is worth $3.2bn

Related tags Sports nutrition Bodybuilding

Supplement manufacturer and retailer GNC has launched a new range of sports products for the ‘ultra serious’ male aged from 18 to 39.

The range, launched to coincide with the 2011 Arnold Sports Festival, the largest multi-sport and high-performance event in the nation, consists of four products called Ravage, Refine, Re-Built Mass, and Re-Forge.

According to the company, the products are designed to maximize training for superior muscle development through a core arsenal of pre-workout, super mass gainer, anabolic amplifier, and thermogenic igniter products.

"The Beyond Raw customer is in an elite class of serious athletes, completely dedicated to his sport and achieving the muscular results needed to excel at all levels,"​ said Tasso Koken, executive VP of merchandising. "He expects nothing short of the most advanced, highly developed, science-based formulas in the category. He is seeking to elevate his physique and reach a new level of muscular development. And he is ultra serious about his training. "

The most recent figures available value the global sports nutrition market at a massive US$4.7bn, with North America ($3.2bn) and western Europe ($713.6m) dominating the podium.

"GNC has been the launching pad for major sports nutrition advances over the last three decades," ​said Jeff Hennion, executive VP marketing/chief branding officer. "And GNC has been the title sponsor of the Arnold for 11 straight years. What better place to sample the GNC Beyond Raw line, highly advanced premium products available for the most serious and knowledgeable athletes in the world."

GNC financials

The Pittsburgh-based company recently reported an adjusted EBITDA for the fourth quarter of 2010 of $58.4 million, which represents a $7.8 million (15.3 percent) increase over the adjusted EBITDA of $50.6 million for the fourth quarter of 2009.

Adjusted EBITDA was reported as 13.4 percent as a percentage of revenue in the fourth quarter of 2010, compared to 12.5 percent in the fourth quarter of 2009, said the researchers.

Related news

Show more

Related products

show more

Nootropics Report 2.0: Brain Health Insights

Nootropics Report 2.0: Brain Health Insights

Content provided by dsm-firmenich | 22-Feb-2024 | Insight Guide

The brain health market is constantly growing and evolving, with more consumers looking for innovative ways to support total mind and body wellness.

KEEP CALM & RELISSA™

KEEP CALM & RELISSA™

Content provided by Indena | 03-Oct-2023 | White Paper

Indena focused on achieving an optimized delivery and formulation of the Melissa officinalis’s phytonutrients: Relissa™, Melissa Phytosome™. The ingredient...

A Premium Product for Men's Health

A Premium Product for Men's Health

Content provided by Chemical Resources (CHERESO) | 03-May-2023 | White Paper

Testosterone deficiency is increasingly recognized as a significant health problem in men.

Related suppliers

Follow us

Products

View more

Webinars